Skip to content

Author

Sara Ladak

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Adoption and practice variation of DPYD genotyping prior to fluoropyrimidine therapy at two Canadian cancer centres.

528 Background: Fluoropyrimidines are widely used in the treatment of solid malignancies. Variants in the dihydropyrimidine dehydrogenase ( DPYD ) gene increase the risk of severe fluoropyrimidine-associated toxicity. Following guidance from Ontario Health (Cancer Care Ontario) recommending DPYD genotyping...

Sara Ladak, L. Thanabalachandran, Alisia Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.